AngioDynamics (ANGO)
(Delayed Data from NSDQ)
$6.31 USD
+0.04 (0.64%)
Updated May 31, 2024 04:00 PM ET
After-Market: $6.31 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth D Momentum D VGM
Brokerage Reports
0 items in cart
AngioDynamics, Inc. [ANGO]
Reports for Purchase
Showing records 261 - 280 ( 410 total )
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Rev Growth Challenges Were Already There, Just More Evident This Quarter
Provider: KEYBANC CAPITAL MARKETS
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
ANGO Has Nothing to Lose but Some Legal Fees; Sets Up TFX with a Win/Win
Provider: KEYBANC CAPITAL MARKETS
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Investor Day Takeaways; Maintain SW
Provider: KEYBANC CAPITAL MARKETS
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Downgrading to SW; Revenue Growth Remains the Challenge
Provider: KEYBANC CAPITAL MARKETS
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Stability and Operational Execution; Next Step a More Defined LT Growth Strategy
Provider: KEYBANC CAPITAL MARKETS